Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the Southeastern United States.

Journal Article

BACKGROUND: Women and minorities continue to account for a higher proportion of AIDS incidence and mortality than their male and white counterparts. This study examined whether race and gender were associated with antiretroviral use among HIV-infected individuals in the southeastern US. METHODS: Multivariate regression analyses were used to identify whether race and gender predicted use of a protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) from 1996 to 2000 among individuals receiving HIV primary care. RESULTS: Female gender and nonwhite race were significantly associated with a lower likelihood of being prescribed a PI or NNRTI at baseline. At the follow-up measure three years later, fewer individuals of minority race and female gender were prescribed a PI or NNRTI; however, these differences had declined and were no longer statistically significant. CONCLUSIONS: Efforts are needed to improve prompt access to advances in HIV therapeutics for women and minorities and to address continued disparities in HIV care by race and gender.

Full Text

Duke Authors

Cited Authors

  • Reif, S; Whetten, K; Thielman, N

Published Date

  • August 2007

Published In

Volume / Issue

  • 100 / 8

Start / End Page

  • 775 - 781

PubMed ID

  • 17713302

International Standard Serial Number (ISSN)

  • 0038-4348

Digital Object Identifier (DOI)

  • 10.1097/SMJ.0b013e3180f626b4

Language

  • eng

Conference Location

  • United States